According to Fitch Ratings (Fitch) forecasts that by 2010, the U.S. health care market outlook is not optimistic about the unemployment rate continued to rise due to public Health Insurance Decline to pay will be the main obstacle to influence the market recovery. In addition, due to health system reform, health care coverage, as well as changes in the level of public payment uncertainty will affect the market for the better. Although signs of U.S. economic recovery has been shown, it is expected that by 2010, the American public will continue to maintain a high level of unemployment. The high unemployment rate directly affects the health insurance coverage and the general public on the health consumer's capacity to pay, so Americans will continue to compress routine health expenses, and reduce non-essential care. From the profit perspective, the benefit cost compression and internal restructuring, the industry before interest, taxes, depreciation and amortization profit (EB IT DA) is still expected to maintain a stable level. All in all, flexibility and stability of capital expenditure plus the profit level will help the industry maintain a stable free cash flow. Congress is committed to health care reform legislation, the House of Representatives has voted to adopt a health care system reform bill, but the Senate has the new version of the medical reform bill has not voted. Therefore, the reform is what impact the entire industry will still have large uncertainties. Currently, the main focus on key issues of reform coverage, public pay levels and industry competition several fronts. The coverage, if the expansion of coverage to achieve the goal, on the industry development will be a positive factor, but Fitch also suggested that for the control of total health expenditure, in the coverage, while public health will decline to pay inevitable, leading to corporate profits decline. Public coverage ratio of the pressure mainly from the decline in Medicare spending, and other constraints related to the reform. Which affect the profitability lies in the expansion of insurance coverage is sufficient to offset the reduction in gross margin, so that the profit levels remain relatively stable. Currently, health care reform will be difficult to assess the competition situation on the impact that certainty is one of the restrictive policy will change the industry is expected in some areas, leading to adjustments in corporate strategy. These strategic adjustments will make enterprises more active M & A, and brought large-scale effects of M & A activity, and thus to promote more loan to play more in the short term leverage. U.S. Pharmaceutical Industry Generally focus on maintaining adequate cash flow. According to statistics the third quarter of 2009, the situation, the U.S. pharmaceutical company in the last financial year, free cash flow of about 46 billion U.S. dollars. However, Fitch estimated the company, of which about two-thirds of the cash balances are outside the United States and should flow back to the United States. Solvency analysis from the industry, the coming year remain more optimistic level, debt level will reach 5.2 million U.S. dollars or 93% high. We are high quality suppliers, our products such as plate rolling machine Manufacturer , roll formers Manufacturer for oversee buyer. To know more, please visits steel roll forming machine.
Related Articles -
plate rolling machine Manufacturer, roll formers Manufacturer,
|